TLR signaling by tumor and immune cells: a double-edged sword
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
http://www.nature.com/articles/1210904.pdf
Reference102 articles.
1. Abiko Y, Mitamura J, Nishimura M, Muramatsu T, Inoue T, Shimono M et al. (1999). Pattern of expression of beta-defensins in oral squamous cell carcinoma. Cancer Lett 143: 37–43.
2. Akira S, Uematsu S, Takeuchi O . (2006). Pathogen recognition and innate immunity. Cell 124: 783–801.
3. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA . (2001). Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732–738.
4. Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD et al. (1999). Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285: 736–739.
5. Andersen MH, Schrama D, Thor Straten P, Becker JC . (2006). Cytotoxic T cells. J Invest Dermatol 126: 32–41.
Cited by 316 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Toll-like receptor (TLR) 4 is a potent prognostic factor in prostate cancer associated with proliferation and invasion;Pathology - Research and Practice;2024-08
2. Plasmacytoid dendritic cells at the forefront of anti-cancer immunity: rewiring strategies for tumor microenvironment remodeling;Journal of Experimental & Clinical Cancer Research;2024-07-17
3. Effects of toll-like receptor agonists and SARS-CoV-2 antigens on interferon (IFN) expression by peripheral blood CD3+ T cells from COVID-19 patients;Experimental and Molecular Pathology;2024-06
4. Recent Insights into the Molecular Mechanisms of the Toll-like Receptor Response to Influenza Virus Infection;International Journal of Molecular Sciences;2024-05-29
5. TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial;Nature Communications;2024-05-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3